Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,359 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibody after allogeneic hematopoietic stem cell transplantation.
Tamaki M, Matsumi S, Nakasone H, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Yoshimura K, Gomyo A, Tanihara A, Okada Y, Kusuda M, Kameda K, Kimura SI, Kako S, Kanda Y. Tamaki M, et al. Among authors: kanda y. Bone Marrow Transplant. 2022 Sep;57(9):1382-1388. doi: 10.1038/s41409-022-01730-6. Epub 2022 Jun 4. Bone Marrow Transplant. 2022. PMID: 35661835 Free PMC article.
Limited efficacy of lamivudine against hepatitis B virus infection in allogeneic hematopoietic stem cell transplant recipients.
Ohnishi M, Kanda Y, Takeuchi T, Won Kim S, Hori A, Niiya H, Chizuka A, Nakai K, Saito T, Makimoto A, Tanosaki R, Watanabe T, Kobayashi Y, Tobinai K, Takaue Y, Mineishi S. Ohnishi M, et al. Among authors: kanda y. Transplantation. 2002 Mar 15;73(5):812-5. doi: 10.1097/00007890-200203150-00027. Transplantation. 2002. PMID: 11907433
Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimen.
Kojima R, Kami M, Nannya Y, Kusumi E, Sakai M, Tanaka Y, Kanda Y, Mori S, Chiba S, Miyakoshi S, Tajima K, Hirai H, Taniguchi S, Sakamaki H, Takaue Y. Kojima R, et al. Among authors: kanda y. Biol Blood Marrow Transplant. 2004 Sep;10(9):645-52. doi: 10.1016/j.bbmt.2004.06.003. Biol Blood Marrow Transplant. 2004. PMID: 15319776 Free article.
In vivo alemtuzumab enables haploidentical human leukocyte antigen-mismatched hematopoietic stem-cell transplantation without ex vivo graft manipulation.
Kanda Y, Oshima K, Asano-Mori Y, Kandabashi K, Nakagawa M, Sakata-Yanagimoto M, Izutsu K, Hangaishi A, Tsujino S, Ogawa S, Motokura T, Chiba S, Hirai H. Kanda Y, et al. Transplantation. 2005 May 27;79(10):1351-7. doi: 10.1097/01.tp.0000158718.49286.14. Transplantation. 2005. PMID: 15912103 Clinical Trial.
Chest computed tomography of late invasive aspergillosis after allogeneic hematopoietic stem cell transplantation.
Kojima R, Tateishi U, Kami M, Murashige N, Nannya Y, Kusumi E, Sakai M, Tanaka Y, Kanda Y, Mori S, Chiba S, Kusumoto M, Miyakoshi S, Hirai H, Taniguchi S, Sakamaki H, Takaue Y. Kojima R, et al. Among authors: kanda y. Biol Blood Marrow Transplant. 2005 Jul;11(7):506-11. doi: 10.1016/j.bbmt.2005.03.005. Biol Blood Marrow Transplant. 2005. PMID: 15983550 Free article.
Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program.
Kato K, Kanda Y, Eto T, Muta T, Gondo H, Taniguchi S, Shibuya T, Utsunomiya A, Kawase T, Kato S, Morishima Y, Kodera Y, Harada M; Japan Marrow Donor Program. Kato K, et al. Among authors: kanda y. Biol Blood Marrow Transplant. 2007 Jan;13(1):90-9. doi: 10.1016/j.bbmt.2006.09.002. Biol Blood Marrow Transplant. 2007. PMID: 17222757 Free article.
1,359 results